| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $940K | — | +118.7% |
| Cost of Revenue | $496K | — | +52.2% |
| Gross Profit | $445K | — | +326.5% |
| R&D Expense | $50K | — | -16.0% |
| SG&A Expense | $405K | — | +51.8% |
| Operating Income | -$1.1M | — | +18.7% |
| Interest Expense | $261K | — | -0.1% |
| Net Income | -$1.9M | — | -17.7% |
| EPS (Diluted) | -$0.01 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $427K | +392.4% | +296.8% |
| Inventory | $1.1M | -32.9% | +72.4% |
| Current Assets | $4.7M | +156.9% | +127.9% |
| Total Assets | $5.9M | +88.3% | +69.4% |
| Current Liabilities | $10.0M | -19.5% | +9.0% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$50K | — | +93.0% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $44K | — | +153.6% |
| Free Cash Flow | -$50K | — | +94.6% |
| $13.0M |
| -0.5% |
| +19.8% |
| Stockholders' Equity | -$7.2M | +28.2% | +3.4% |